Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $20.67B as of Tuesday, July 28, 2026.
ENTERPRISE VALUE (EV)
$20.67B
United Therapeutics Corporation
Market Cap
$22.23B
Enterprise Value (EV)
$20.67B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| United Therapeutics Corporation (UTHR) | $22.23B | $20.67B |
| Moderna, Inc. (MRNA)vs › | $22.14B | $20.59B |
| STERIS plc (STE)vs › | $22.45B | $23.82B |
| BioNTech SE (BNTX)vs › | $23.38B | $12.23B |
| Viatris Inc. (VTRS)vs › | $20.80B | $33.34B |
| West Pharmaceutical Services, Inc. (WST)vs › | $23.72B | $23.61B |
| Waters Corporation (WAT)vs › | $25.02B | $30.13B |
| Labcorp Holdings Inc. (LH)vs › | $25.77B | $31.47B |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.52B | $25.58B |
| Incyte Corporation (INCY)vs › | $25.96B | $22.01B |
Market Cap
$22.23B
Total Debt
$0.00
Cash
$1.56B
Enterprise Value
$20.67B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
